Sterling Capital Management’s Terns Pharmaceuticals TERN Stock Holding History

Sterling Capital Management’s Portfolio TERN Stock Details TERN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-3,184	Closed	-$168K	–	3414
2026 Q1	$168K	Sell	3,184 -1,759	-36%	-$72.2K	﹤0.01%	1243
2025 Q4	$200K	Sell	4,943 -46	-0.9%	-$1.06K	﹤0.01%	1315
2025 Q3	$37.5K	Buy	4,989 +3,109	+165%	+$19.9K	﹤0.01%	1864
2025 Q2	$7.01K	Buy	1,880 +728	+63%	+$2.27K	﹤0.01%	2328
2025 Q1	$3.18K	Sell	1,152 -949	-45%	-$3.88K	﹤0.01%	2382
2024 Q4	$11.6K	Buy	2,101 +1,918	+1,048%	+$13K	﹤0.01%	2096
2024 Q3	$1.53K	Buy	+183	New	+$1.51K	﹤0.01%	2326

Other funds holding TERN

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Sterling Capital Management's TERN Position: Q2 2026 in Review

Sterling Capital Management sold out of Terns Pharmaceuticals (TERN) in Q2 2026, closing a stake of 3,184 shares — an estimated $168K sold.

Sterling Capital Management first reported a position in TERN in Q3 2024 and held it in 7 quarters. The position peaked at $200K in Q4 2025. 1 fund tracked by Wall St. Rank holds TERN as of Q2 2026.

Sterling Capital Management reported no remaining Terns Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
Sterling Capital Management sold 3,184 Terns Pharmaceuticals shares in Q2 2026, an estimated $168K.
Sterling Capital Management first reported a position in Terns Pharmaceuticals in Q3 2024 and held it in 7 quarters.
Sterling Capital Management's Terns Pharmaceuticals position peaked at $200K in Q4 2025.
1 fund tracked by Wall St. Rank held Terns Pharmaceuticals as of Q2 2026.

Based on Sterling Capital Management's 13F filing for Q2 2026, filed 28 Jul 2026.